Niraparib as a therapeutic agent for the treatment of ovarian cancer meningeal dissemination with BRCA1 mutation
Niraparib as a therapeutic agent for the treatment of ovarian cancer meningeal dissemination with BRCA1 mutation
复制标题
尼拉帕尼作为治疗 BRCA1 突变卵巢癌脑膜播散的治疗剂
DOI:
10.1111/jog.15663
复制
发表时间:
2023
影响因子:
1.6
通讯作者:
Kajiyama Hiroaki
中科院分区:
文献类型:
--
作者:
Nei Takashi;Tamauchi Satoshi;Ikeda Yoshiki;Yoshikawa Nobuhisa;Niimi Kaoru;Kajiyama Hiroaki
This study analyzed a 63‐year‐old woman with hereditaryBRCA1mutation. She underwent interval debulking surgery after neoadjuvant chemotherapy for high‐grade serous ovarian carcinoma (HGSOC). After 2 years of postoperative chemotherapy, she developed headache and dizziness, and a suspected metastatic cerebellar mass in left ovary was detected. Pathological analysis of the mass revealed HGSOC, which was removed surgically. Eight months and another 6 months after the surgery, local recurrence was noted; hence, she underwent CyberKnife treatment. After 3 months, cervical spinal cord metastasis was found, evidenced by left shoulder pain. Moreover, meningeal dissemination was present around the cauda equina. Chemotherapy treatment, including bevacizumab, was ineffective and increased lesions were observed. After CyberKnife treatment for the cervical spinal cord metastasis, niraparib was initiated for the meningeal dissemination. The cerebellar lesions and meningeal dissemination improved within 8 months of niraparib treatment. Although meningeal dissemination is challenging to treat, niraparib may be useful inBRCA‐mutated HGSOC.
登录
查看更多内容
影响因子:
2.4
作者:
Kim, DY;Lee, KW;Kim, NK
通讯作者:
Kim, NK
影响因子:
2.5
作者:
Zhan, Qiong;Miao, Feng;Liang, Xiaohua
通讯作者:
Liang, Xiaohua
影响因子:
45.3
作者:
Jackman, David M.;Holmes, Alison J.;Johnson, Bruce E.
通讯作者:
Johnson, Bruce E.
影响因子:
0.9
作者:
Gray, Simon;Khor, Xiao Ying;Yiannakis, Dennis
通讯作者:
Yiannakis, Dennis